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Abstract 
The development of antimicrobial resistance among clinical infections has engendered a 
detrimental effect in pathogenesis of disease. This has raised equivocal concerns for their 
prevention and treatment. Antibiotics are chemical compounds used to treat bacterial 
infections. Resistance to these antibiotics arise through de-novo mutation under clinical 
antibiotic selection or by acquisition of mobile genes, often plasmids that have evolved over a 
period of time in bacteria (Wellington et al. 2013). Extended Spectrum beta Lactamases 
(ESBL) are the group of plasmid-mediated, complex and rapidly evolving bacterial genes 
posing a therapeutic challenge in hospitalized and community-based patients. (Rawat & Nair 
2010). The increasing incidence of multidrug resistance among Escherichia coli, Pseudomonas 
species and the group of Enterobacteriaceae has made it compelling to explore the genetic 
basis of the infection. Genome sequencing and use of the phylogenetic tools help trace the 
genetic determinants of the pathogen. The genotypic basis provide insight to any changes in 
the order and pattern of inheritance that alter the disease physiology. This can thus aim to 
control hospital associated infections. 
We have analysed the genotypic features of 99 clinical isolates [n=99; Escherichia coli (n=12), 
Pseudomonas aeruginosa (n= 30) and genus of Enterobacteriaceae (n= 57)] from University 
Hospital Geelong and Aged care home by whole genome sequencing as different projects. 
Potential antibiotic resistance genes and evolutionary relatedness of the isolates were tracked 
by using genomic and metagenomic tools.  
The phylogenetic map of Escherichia coli represents a distant evolutionary history among each 
other for both resistance and sensitive strains. There were 42 known antibiotic resistance gene 
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groups in these genomes with the observation of ESBL gene groups, BlaEC and CTX-M, in 
the resistant strains compared to the same sensitive ones. Pseudomonas aeruginosa 
demonstrates a wide range of geographic relatedness using the   public NCBI database and 
comparing common Single Nucleotide Polymorphism (SNPs) between all strains.  Almost all 
of these genomes have around 200 antibiotic resistant genes. It was observed that there were 
three extra genes, which actually were the frame breaks of Open Reading Frames and 2Kb 
inserted in isolate EA- 87 compared to isolate EA-86 from the same patient. These genes were 
the antibiotic resistance repressor like MexR; a haeme utilising exoprotein and a porin, 
somewhat like OprB, which is known as a virulence protein.  All these mutations are due to 
disruptions of ORFs giving loss of function. The isolates from the genus of Enterobacteriaceae 
were identified metagenomically, a small number of the determinations contradicted the 
clinical metadata. The isolate EA-30 was found to be the nearest match to Enterobacteriaceae 
bacterium 8376wB9 from bull faeces from Tanzania. Only a small proportion (9%) of the two 
genomes shared a high level of identity (> 99%). Interestingly, the rest of the genomes are quite 
different.  EA-030 is a novel species of pathogenic Enterobacteriaceae. 
 These results provide insight to healthcare workers on the genetics of bacteria and changes in 
resistant patterns potentially helpful in formulating management strategies in the future for 
outbreak control. 
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CHAPTER I - INTRODUCTION 
 
1. Overview  
The increasing incidence of Gram-negative bacterial (GNB) infections is presenting 
therapeutic challenges in medical prognosis. The majority of these originate from unknown 
sources, cross infections among patients, health care equipment, contaminated environment, 
and health personnel (Vonberg et al. 2011). This has tremendously inundated the number of 
Intensive Care Unit (ICU) patients with multidrug resistant (MDR) cases thereby exacerbating 
the pathophysiology of the disease (Gastmeier at al. 2007). There is an outbreak of the 
healthcare associated infection (HAI), also previously known as nosocomial infections. 
According to the CDC (2020), “Outbreak is the state of the occurrence of more cases of disease 
than expected in a given area or among a specific group of people over a particular period of 
time”. This might also be due to the state of carrying pathogens like MDR Pseudomonas 
species. The most prevalent GNB promoting healthcare associated infections are Escherichia 
coli, Pseudomonas species, Klebsiella species and Enterobacter species. HAI are the range of 
infections that occur as a result of healthcare intervention. One of the major challenges with all 
these is the development of resistance to a wide range of antimicrobial agents.  The World 
Health Organisation (2019) presents the fact that around 30 percent of the patients admitted to 
ICUs are affected by at least one HAI. Similarly, out of every 100 patients, 7 from the 
developed and 10 from developing countries are at risk of at least one HAI. This data 
emphasizes the need to investigate the clinical isolates that are responsible for outbreaks. 
   Escherichia coli is a common gut microbiota, the majority of which are non-pathogenic to 
humans. Around 10 to 15% of these have the tendency to cause illness especially when acquired 
by the intake of contaminated food (Brzuszkiewicz et al. 2011).  The report by European Union 
(2017) presents a fact that 0.9% of outbreaks of foodborne sickness is due to this organism. 
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Moreover, it’s concerning to the notion that it occupies a considerable share of nosocomial 
infection across the globe (Hamadi et al. 2008)! Acquisition of antibiotic resistance in E. coli 
is by the horizontal gene transfer mechanisms and have developed over time (Capita & Alonso-
Calleja 2013). ESBL E. coli is imposing therapeutic challenges in the hospital arena. The highly 
used antibiotic beta lactams such as penicillins, cephalosporin are ineffective against this 
pathogen. There are concerns over the high likelihood of transfer of resistance genes to other 
pathogenic clinical isolates. Hence these group of bacteria are perceived as custodians for 
antibiotic resistance.  
Pseudomonas aeruginosa is a ubiquitous gram- negative pathogen that has high diversity in its 
genotype. They are cosmopolitan in distribution and have a high mutation tendency. According 
to AR Threats Report (2019), multidrug resistant Pseudomonas aeruginosa caused around 
32,600 infections among the hospital patients with death tolls up to 2700 in United States in 
2017. Patients on ventilators, the use of catheters and wound surgery patients are at high risk 
of transmission. The spread of resistance, be it beta lactam or fluoroquinolone, in Pseudomonas 
aeruginosa subsequently alters the mechanism of spread in the host. It is observed that efflux 
mediated resistance is common in the isolates derived from cystic fibrosis patients compared 
to isolates from urine or wound infections. Mutations in parC and gyrA predominate in the 
latter infections (Jalal et al. 2000). They invade and colonizes chronically in the patients. Their 
nonmotile phenotype at the infection site provides a survival advantage by preventing 
phagocytosis and preserving the energy (Mahenthiralingam et al. 1994). This is thus 
noteworthy to extrapolate the existing diversity of Pseudomonas sps for control of hospitalised 
and community borne cases. 
Klebsiella pneumoniae belongs to the Enterobacteriaceae family and is one of the leading 
causes of hospital acquired infection globally (Peltier at al. 2019). They possess strong 
virulence and demonstrates high drug- resistant phenotypes. Carbapenemase producing K. 
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pneumoniae are the major threat while resistance against Polymyxin has been highly associated 
with mortality (Bogdanovich et al. 2011). In neonatal ICUs, 20.3% of the outbreaks are 
associated with Klebsiella species (Gastmeier et al. 2015).  
The study of antimicrobial resistance in the community of healthcare settings in Australia is 
limited. Every year there is a rise in approximately 165,000 HAIs in Australia (Mitchell et al. 
2017). There is a need for a national HAI surveillance program to accurately address the 
concerns of rising cases and formulate a national infection prevention initiative (Russo et al. 
2018) 
A vast majority of treatment is associated with microbiological characterisation and serotyping 
(Schrader et al. 2008; Prager at al. 2003) which are all species dependent phenotypic assay. 
They are more time consuming and follow cumbersome processes producing low taxonomic 
resolution (Outhred at al. 2015).  In addition, they fail to distinguish the closely related 
outbreaks and virulence features associated with it. Hence the need for reliable robust genetic 
techniques is underway considered as an advanced outbreak management protocol. This is 
based on the principle that the exploration of the genomic constituents of the pathogen help 
determine the virulence/resistance genes, even slight changes in them, and their regulatory 
components, making pathogenesis determination site specific and faster. Whole genome 
sequencing (WGS) remains as a potential technology to unveils all the genomic characteristics 
of the pathogen thus improving outbreak analysis (Dallman et al. 2015). Clinical metagenomics 
analyse the microbial and host genetic elements in the patients changing the way the physicians 
diagnose the disease.  Different areas of this application come into practise including host-
microbe interaction, gene expression, putative changes in the genome and antimicrobial 
resistance (Chiu & Miller 2019). This is helpful for tracing the overall physiology of host -
pathogen infections.  
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1.1 Antimicrobial resistance 
Antimicrobial resistance is one of the biggest threats to global health, food security and 
development. According to the World Health Organisation [WHO] (2019) it is defined as the 
inefficacy of the drugs to treat infections caused by bacteria, fungus, parasites and viruses. 
Generally, antibiotics are used to treat bacterial infection. There is a growing number of 
infections like tuberculosis, salmonellosis, pneumonia, urinary tract infections that are hard to 
treat due to the development of resistance in the causal bacteria. Resistance arises naturally 
over time, usually through genotypic changes to the microorganisms, though epigenetic 
changes have also been observed. New antibiotic resistance mechanisms are emerging and 
spreading globally, and as a result, medicines become ineffective and infection persists in the 
body, increasing the risk of spread to others, causing fatality and incurring a huge economic 
loss in many cases (WHO 2019).  
 
1.1.1 Types of antibiotics 
Antibiotics are chemical compounds used to treat bacterial infections. There are different 
classes of   antibiotics based on the principle and mechanism of action. Mechanism includes 
inhibition of cell wall synthesis (e.g. β-lactams, glycopeptide agent), protein synthesis 
(macrolides and tetracycline), nucleic acid synthesis (fluoroquinolones, rifampicin), and 
disruption of bacterial membranes (polymyxins) and metabolic pathways (trimethoprim) 
(Tenover 2006). Based on the target specificity, they are of two types. Narrow spectrum 
antibiotics that target specific groups of bacteria like gram negative or positive (e.g. old 
Penicillins, macrolides) while broad spectrum is used to treat a wide range of bacterial 
infections (e.g. aminoglycosides, quinolone, second and third generation cephalosporin).   
Following the development of Penicillin by Fleming in 1928 a number of antimicrobial 
compounds have been developed (Figure 1) and over time, resistance has spread rampantly.   
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In hospitals, the success of major surgery and cancer treatment is impossible without 
antibiotics. The widespread development of resistance increases the cost of health care and it 
is projected that without meaningful change, antibiotics resistance could cause grave 
consequences in the future. One perilous projection made by the CDC (Centre for Disease 
Control) states that resistant infections will kill 10 million people per year by 2050, nearly two 
million more than would die of cancer, incurring a loss of above 100 trillion dollars to world 
economy! (O’Neill 2014.) 
  
 
 
 
 
 
 
 
 
 
Figure 2: Timeline of antimicrobial drug discovery versus the development of 
resistance. 
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1.1.2 Mechanism of antibiotic resistance 
Owing to the varieties of antibiotics, multidrug resistance has evolved through a number of 
new resistance mechanisms. Bacteria may be resistant through de-novo mutation or by 
acquiring resistance genes from other organisms via conjugation, transformation or 
transduction, transposons or plasmids. Mutation in general alter the antibiotics’ action by 
modification of the antibiotic target reducing the antibiotic uptake, activation of the efflux 
pumps or alteration in the metabolic pathway via regulatory operons (Munita & Arias 2016). 
Acquired resistance genes can guide the bacteria to produce inhibitory enzymes to antibiotics 
or to express efflux systems (Figure 2) that prevent the drug from reaching the target cell or 
modify the drug’s target site or produce an alternative pathway to bypass the action of drug. 
(Tenover 2006). Conjugation utilises mobile genetic elements like plasmids or transposons to 
acquire resistance genes from other bacteria. Another important strategy to accumulate 
resistance genes is by integrons which is a site-specific recombination system in the form of 
mobile gene cassettes that is capable of recruiting open reading frames (Thomas & Nielsen 
2005).  The evolution of an antimicrobial resistance mechanism and the spread of the bacteria 
with genetic determinants of resistance is proposed to be a major public health threat globally 
(Tang, Apisarnthanarak & Hsu 2014). 
In the mechanistic approach of antimicrobial resistance, there is the biochemical changes in the 
physiology of the cell due to the chemical structure of antibiotics. The biochemical basis of 
resistance involves altering and restricting the target site, chemical modification of the 
antimicrobial compound and decreasing charge in the sites.   The cells have evolved the cellular 
machinery to resist different doses of drugs. For instance, in the gram-negative bacteria, 
resistance to beta lactam is by the production of beta lactamases giving rise to Extended 
Spectrum Beta Lactamase (ESBL) resistance while it is by the modification of the target site 
among gram positive bacteria.   
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Figure 2: Mechanism of ESBL resistance in gram positive and gram-negative bacteria. (Tang, 
Apisarnthanarak & Hsu 2014) 
 
1.1.3 Extended Spectrum Beta Lactamase Resistance 
Extended Spectrum Beta Lactamase (ESBL) resistance is one of the resistance mechanisms 
that has serious implications in the treatment of severe infection in hospitals (Voulgari et al. 
2013). ESBL are enzymes that affect the action of β- lactam antibiotics and are produced in a 
clade of bacteria containing E. coli, Klebsiella, Salmonella and Yersina species. Beta lactam is 
one of the most important antimicrobials in both human and veterinary medicine (Health line 
2017). They work by interfering with bacterial cell wall synthesis. Different types of this 
antibiotics are Penicillin, Cephalosporin, and third generation carbapenems.  According to 
Health line (2017), the ESBL phenotype is found in 7-12% of E. coli and is often found in 
urinary tract infections. Its infection is treated by beta lactam antibiotics like penicillin and 
cephalosporin antibiotics but due to the evolution of ESBL strains, it has become a threat to 
community health. For instance, resistance in E. coli to fluoroquinolones antibiotics for treating 
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urinary tract infection is widely spreading. Apart from this, Vancomycin resistant 
Enterococcus, methicillin resistant Staphylococcus aureus (MRSA), and resistance 
development in other diseases like influenza, tuberculosis and even HIV has grabbed attention 
globally.  
 
 
1.1.4. Genetics of ESBL resistance 
Enzyme catalysed modification of antibiotics is a major mechanism of antibiotic resistance. 
Thousands of enzymes have been identified that can degrade or modify antibiotics of different 
classes including β-lactams, aminoglycosides, phenolics and macrolides. The early β- 
lactamases were active against first generation β-lactams followed by ESBLs’ that have activity 
against oxyimino-cephalosporins. The evolution of diverse ESBLs’ enzymes in gram negative 
bacteria has led to the emergence of resistance to all β-Lactam antibiotics (Lynch III 2013). 
There are hundreds of CTX-M genes that encodes ESBLs (Poirell et al. 2012). These ESBLs 
are hypothesised to originate from point mutation of beta- lactamase (bla)-encoding genes that 
belong to 2 principle classes, TEM and SHV types (Ramadan et al. 2019). The CTX-M14 and 
CTX-M15 enzymes have been the most isolated ESBLs worldwide from cephalosporin 
resistance E. coli and K.  pneumoniae isolates (Zhao et al 2013). These genes are found widely 
in gram negative bacteria and are often associated with human, animal and environmental 
isolates of Enterobacteriaceae (Cottell et al. 2012). There is a huge variation in ESBL bacteria 
and hence in the enzymes they produce (Livermore et al. 2006). This has expanded the concept 
of a resistome to be a unique reservoir of antibiotic resistance genes along with the genetic 
components involving in gene transfer (Canton 2009). The spread of the resistance genes in 
the biosphere substantially increases the rate of human bacterial infection. Most current 
antibiotics are derived from products biosynthesised by fungal or complex prokaryote species, 
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and thus resistance has been present in the biosphere for hundreds of millions of years (Keswani 
et al. 2019). 
 
1.1.5 Significance of ESBL transmission 
The concept of resistome transmission of the ESBLs gene among humans, animals and the 
environment has challenged healthcare facilities globally. The most common devastating type 
of ESBL is found in Escherichia coli.  In the 2000s, the epidemiology of ESBL producing 
organisms changed as E coli producing CTX-M ESBL type was marked as an important cause 
of community acquired urinary tract infections (Pitout et al. 2005).  The transmission of ESBL 
bacteria has been more complicated as ESBL genes encodes self-transmissible plasmids, which 
can be exchanged between the same or different species of Enterobacteriaceae (Stadler 2018). 
Different ongoing research on the genomics of the resistance bacteria have revealed huge 
diversity in them indicating the complexity of control and management of resistant bacteria.   
The increasing burden of phenotypically variable, but genetically homogenous resistant E.  coli 
has been observed in urinary tract infections (Clark et al. 2012), demonstrating the difficulty 
of tracing resistance through phenotype alone. 
1.1.6. Situation of antibiotic resistance in Australia 
In Australia, resistance to third generation cephalosporin and other orally available antibiotics 
is building (Fasugba et al. 2016). One of the most prevalent current clinical problems in 
Australia is the increasing frequency of resistance of gram-negative bacteria expressing 
extended spectrum beta lactamases. These organisms were first identified as causing 
nosocomial infections in Europe in the 1980s (Knothe 1983). In Australia they have been 
associated with community infections through hospital outbreaks and nursing home infections 
(Stuart 2011). 
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1. 2. CLINICAL ISOLATES 
1.2.1 Pseudomonas aeruginosa 
 
  1. 2.1.1. Introduction 
 Pseudomonas aeruginosa is a Gram- negative, rod shaped, monoflagellated and non-spore 
forming bacterium. They are ubiquitous in nature so are found in varied environmental 
conditions such as moist surfaces, water, and different ecosystems (Peix et al. 2009). They are 
opportunistic pathogens causing infections in plants, human and animals; one of the major 
contributors of nosocomial infections among the immuno-compromised patients like cancer or 
neutropenic patients (Pagani et al. 2004). Their prevalence varies by host specificity, 
geographic distribution, exposure to the spectrum of antimicrobials and the clinical setting. 
(Lin et al. 2016). There are various reasons why Pseudomonas is abundant in a wide arc from 
the environment to intensive care units.  Innate resistance mechanisms, multidrug resistance, 
ability to survive even in moist environment are some of these. (Pachori, Gothalwal & Gandhi 
2019). They are capable of causing a wide range of infections ranging from respiratory tract 
(Fujitani et al. 2011) to urinary tract (Gomila et al. 2018), soft skin and tissues (Armour et al. 
2007) bacterial keratitis (Nagachandrika et al. 2011), and swimmer ear infection (Wang et al. 
2005). 
 
1.2.1.2 Pathogenesis 
Multiple factors have been involved in the development of disease by Pseudomonas 
aeruginosa, which is generally mediated by Quorum Sensing. They possess two basic sensing 
mechanisms; las and rhl that help cell to cell signalling by the production of autoinducers for 
targeting the specific receptors for activation (O’Loughlin et al. 2013). This induces virulence 
gene expression and biofilm formation (Smith & Iglewski 2003). This involves adhesions, the 
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Type III secretion system among other systems. Adhesion is mediated by type IV pili and 
formation of encapsulated biofilms (Bertrand, West & Engel 2010). According to Hahn (1997) 
this pili is responsible for 90% of the adherence and virulence in a mouse model.  The 
production of the extracellular polysaccharides; alginate from the Polysaccharide- encoding 
locus (pel) and Polysaccharide- synthesis locus (psl) are responsible for the formation of a 
biofilm matrix around the microcolonies (Colvin et al. 2012). This alginate is the component 
found in the sputum of cystic fibrosis patients (Pritt, O’Brien & Winn 2007). This inhibits 
phagocytosis and scavenges reactive oxygen species (Al-Wrafy et al. 2017). Hence the biofilm 
production helps protect the bacteria from host immune response and confers resistance to 
antibiotics (Høiby et al. 2011). However, Wozniak (2003) found no difference in the resistance 
profile in wild-type and alginate- mutant biofilms.  
Pseudomonas aeruginosa interacts with the host via a Type-III secretion system (T3SS) by 
transferring the toxic effector proteins into the cytosol of the host for bacterial survival.  Four 
of the known toxic effectors include exoenzymes S, U, T and Y (Galle et al. 2012). High 
expression of the ExoS have been traced in the clinical isolates of urinary tract and wound 
infections (Mitov, Strateva & Markova 2010). There are other secreted virulence proteins like 
Phospholipase C (PLC), elastase (lasB) and yellow green fluorescent pigment pyoverdine by 
this species. PLC is responsible for when lasB is involved in host colonization and tissue 
damage. Pyoverdine acts as a siderophore for capture of iron and uptake through the specific 
protein receptors on the outer membrane (Wilson et al. 2016). 
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1.2.1.3 Antibiotic resistance in Pseudomonas aeruginosa 
The emerging health concerns of the development of multidrug resistance (MDR) strains of 
Pseudomonas, majorly associated with the nosocomial infections have captured global 
attention. Their ability to resist even in diverse environments and the frequent use of the 
antimicrobials are principle reason to this (Jimenez et al. 2012). Induced response help them 
survive the exposure to rampant antibiotics thereby conferring resistance. Low permeability of 
the outer membrane act as a selective barrier because of which P. aeruginosa is intrinsically 
resistance to antibiotics (Breidenstein at al. 2011).  
There has been increasing incidence of the occurrence of ESBLs’ in clinical isolates of P. 
aeruginosa (Lee et al. 2005). The most prevalent ESBL gene was blaVEB-3, in P. 
aeruginosa (Jeannot 2019). Unlike Klebsiellae and other Enterobacteriaceae, the detection of 
ESBL in Pseudomonas present further difficulty due to greater extent of   impermeability and 
efflux mediated resistance in addition to the presence of inducible AmpC enzymes (Poirel et 
al.  2012). They are also able to produce metallo- beta lactamases (MBL) and chromosomal 
cephalosporinase and lactamases (Manoharan et al. 2010). MBLs are carried on integrons and 
their presence in the blood stream is associated with high mortality (Marra et al. 2012). 
Pseudomonas aeruginosa differs from other beta lactamase bacteria by the presence of the 
ampC gene (Juan et al. 2005).  
Carbapenems are generally used to treat beta lactamase producing Pseudomonas aeruginosa. 
There has been an increasing prevalence of carbapenem resistance in the hospital setting 
(Vitkauskiene et al. 2011). Reports from 14 countries in Europe showed the increased 
prevalence of metallo -beta -lactamases producing Pseudomonas aeruginosa from 12.3% in 
2010 to 30.6% in 2011 (Castanheira et al. 2014). Mutation in specific chromosomal genes is 
another way to acquire resistance among these strains (Ostrer et al. 2019). For instance, 
fluoroquinolone resistance is enhanced by modification of type II topoisomerase; gryA gene 
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and parC gene; that restricts antibiotic binding (Nouri et al. 2016).  Efflux pumps are the other  
resistance mechanism which removes the antibiotics/toxins out of the cytoplasm often due to 
upregulating the expression of the mex operon (Tian et al. 2016). The efflux pump constitute 
the outer membrane protein, the ATP dependent pump and connecting protein (Darzynkiewicz 
et al. 2019). There are  four different efflux systems in P. aeruginosa that belong to the 
resistance-nodulation-division (RND) family including MexAB-OprM, MexCD-OprJ, 
MexEF-OprN, and MexXYOprM (Puzari & Chetia 2017). The overexpression of one or more 
Mex pumps is associated with  MDR- P. aeruginosa (Pan et al. 2016). 
 
 
1.2.2 Enterobacteriaceae 
1.2.2.1 Introduction 
 Enterobacteriaceae are  a large group of gram negative, rod shaped facultative anaerobes . 
They include a wide range of genera like Klebsiella , Salmonella , Shigella, Enterobacter , 
Proteus and Escherichia  coli . They are the normal microbiota in the gut of human. A majority 
of them are associated with urinary tract infections (UTI) but can be a  severe threat when 
spread in the blood stream (National Institute For Communicable Disease 2020).  They are 
known to cause all forms of hospital associated infections (HAI) apart from the enteric, 
nosocomial and community acquired infections. E. coli is a pathogen responsible for the enteric 
fever  (Mishra et al. 2020).  Klebsiella pneumoniae possess strong virulence factors with 
abundant antimicrobial resistance genes (CDC 2013). Carbapenemase producing strain of 
Klebsiella species are the major challenge leading to UTIs, pneumonia and septicemia related 
mortality (Munoz-Price et al. 2013). Salmonella usually transmitted through contaminated food 
source cause typhoid fever affecting the intestinal region of the body (Foley & Lynne 2008 ). 
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The existence of antimicrobial resistance and prominently, multidrug resistance in pathogenic 
members of Enterobacteriaceae has challenged the healthcare system of the world. 
 
 
1.2.2.2 Pathogenesis: 
 Outer membrane protein (OMPs) of the gram negative bacteria play a vital role in bacterial 
virulence  and  pathogenic ability. It has been observed that environmental strains of 
Enterobacter genus have  limited pathogenic potential in the human host (Mishra et al. 2020). 
Klebsiella pneumoniae is a rod -shaped, non motile gram negative bacterium. They possess the 
conserved operon product pbgPE that drives the resistance to cationic antimicrobial agents via 
Lippopolysachharide (LPS) sequence alterations (Granata & Petrosillo 2017). This product is 
positively regulated by PmrAB and PhoQ/PhoP signalling systems that produce the 
transmembrane regulatory protein MgrB  (Cheng et al. 2010) which provides negative feedback 
on signalling via coordination with PhoQ sensor kinase. This regulation has also been found in 
Yersina pestis, Salmonella enterica and E. coli  (Lippa &Goulian 2009).   
 
1.2.2.3 Antibiotic resistance in Enterobacteriaceae 
   Enterobacteriaceae accounts for 60-70% of the gram negative bacteria (Ye et al. 2018).  The 
leading strains are Escherichia coli and Klebsiella that are pathogenic and are common flora 
that cause nosocomial infections (Kumarasamy at al. 2010).  Carbapenems are the widely used 
antibiotics for the treament of this infections. The high rate of  antibiotic resistance  in these 
isolates is complicating the treatment. It is reported that  resistance rate has elevated to upto 
7% in some species of these family (Mushtaq et al. 2013). 
 One of  the main mechanism for resistance of Cabapenem resistant Enterobacteriaceae (CRE) 
strains is the production of carbapenemases. They also produce ESBLs, AmpC enzymes and 
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outer membrane porin (OMP) proteins as other strategy to develop resistance (Satlin et al. 
2017). Carbapenems are the beta lactamases  that uses carbapenes as its substrate. KPC 
enzymes dissociate most of the beta lactams including penicillins , carbapenems and 
cephalosporin in addition to resistance with different other types of antibiotics (Blair et al. 
2015). The premeability of  outer membrane of gram negative bacteria plays a vital role in the 
entrance of the antibiotics. The deletion or reduction in the amount of OMP proteins is 
responsible  for antibiotic resistance. This is by the deletion of OMP proteins and decrease in 
production of beta lactamases,  the Enterobacteriaceae are resistance to Carbapenems. (Khan, 
Maryam & Zarrilli 2017). Similarly the ESBL resistance mechanism is also prevalent in these 
group of bacteria. The detail of which is presented in the above sections.  
   
 
1.3 Genomic analysis of the isolates 
1.3.1 Whole genome sequencing as a tool in outbreak management. 
While several improvements have been made to reduce the health care associated outbreaks, 
the increasing incidence of MDR bacteria continue to peak around the globe (Wong at al. 
2015). According to EPIC II global study report, 36% of ICU patients out of 13796 were 
infected with MDR strains (Vincent ae al. 2009). This parlous fact emphasizes the need of more 
robust technology for the management of the outbreak.  Several phenotypic and molecular 
methods are in conventional practise to curb the spread of the bacteria in hospital settings. They 
generally fail to trace the closely related strains and virulence factor associated with this. 
(Anthony et al. 2013). Whole Genome Sequencing (WGS) stands out to obtain all the related 
genomic characteristics of the bacteria. Due to reduced cost and a convenient process, it could 
be developed as standard outbreak analysis protocol unanimously in all the countries (Rothberg 
et al. 2011; Valouev et al. 2008). 
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Whole Genome sequencing is a process to determine the order of nucleotide of the DNA from 
an organism’s genome. There are different techniques for sequencing based on the type of 
output generated. Capillary sequencing has been replaced by high throughput or next 
generation sequencing such as Illumina sequencing which are based on shotgun random 
sequencing approach. This involves random shearing of the DNA followed by chain 
termination methods to obtain the reads. These reads are then assembled by computer software 
programme like Spades and other assembly tools.  Nanopore technology is generally used to 
produce long reads which is applicable in whole genome sequencing approach. 
 
1.3.1.1 Illumina sequencing  
This technique was used for this research.  It is based on reversible dye terminator that 
help identify single bases as they are introduced into the DNA strands. All of the steps of this 
type take place in a flow cell. The steps involve an enzymatic process and imaging them 
clusters of clonally expanded DNA fragments. Bridge amplification is followed by forward 
and reverse oligo binding at the surfaces of the flow cell lanes. These oligos or primers are 
complementary to the adapter sequences that is introduced during library preparation (Fig 3; 
step 2 & 3). The clonal copies of both Forward and Reverse strand then are generated as a 
cluster.  Sequencing helps generate highly reliable bacterial lineages including mobile genetic 
elements that is crucially important in outbreak management (Buermans & Den 2014).  
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Figure 3:  Steps in Illumina sequencing generating a cluster. (Step 1 to 5) (DMLapato 2015) 
 
1.3.2 Phylogenetic study of the isolates 
The rampant spread of antibiotic resistance has created a dire need to better understand its 
genomics basis and underlying mechanisms to control bacterial infections. The over 
dependence on culture-based methods and concentration on single strains has narrowed the 
understanding of the huge resistome across hosts and environments. Recently, there has been 
an increased interest in utilizing metagenomics tools to analyse the resistance pool. 
Metagenomics can be used for the study of the genetic elements of the pool of organisms from 
the environmental, uncultured source that provides broad insight into population genetics and 
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change over time.  Use of bioinformatics tools to annotate the genome and comparative analysis 
with databases of known bacteria help denote the likelihood of gene mutations leading to 
failure in antibiotic therapy. This further helps explore the diversity of β- lactamase resistance 
genes that promotes proliferation and spread of these genes in clinical settings. Ongoing 
research has projected a unique type of mode of transmission of resistance genes along with 
potent sources of transfer (Ng et al. 2017). Functional metagenomics has been used to 
characterise the diversity of the organism’s genome in the context of  antibiotic resistance (AR) 
genes (Mishra et al. 2020). AR genes have been found to transpose among and within their 
species, thus analysing the flanking sequences around the AR genes through genomic 
neighbourhood analysis can give information about the host organism or the location of the AR 
genes. (Martiny et al. 2011). This information can be helpful in correlating the transmission of 
the resistance in the biosphere.  
 
 
Figure 4: Radial tree generated by unweighted pair group method with arithmetic mean 
(UPGMA) method (Ramadan et al. 2019). It shows relations between different isolates 
according to their beta lactamase genotypes and antibiotic susceptibility phenotypes. 
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Phylogeny is the ancestral history of the organism. Phylogenetic tracking helps determine the 
ancestor of the descendant’s bacteria. It can be correlative to the genetic changes in the resistant 
strain over the period of time. This can be analysed to understand virulence and gene expression 
patterns. The root of the phylogenetic tree represents the lineage of the ancestor whereas the 
tips of the branches are descendants of the ancestor (Figure 5). This tree structure can also be 
arranged in radial fashion (Figure 4) that shows the relation between the isolates from different 
sources (Ramadan et al. 2019). It is a significant way to analyse the novel isolates through 
comparison with the ancestor. It denotes the origin of the isolate, change in their virulence 
gene, any mutation patterns that can be promising in understanding the epidemiology, spread 
and possible control of the infections.  
 
 Recent (Branch- Descendants) 
 
 
             
         Past (Root- Ancestor) 
 
Figure 5: Tree structure in phylogenetic analysis. (Berkeley 2016)  
 
In Australia, the study of the antibiotic resistance has been majorly focused on the 
epidemiology rather than in scrutinized genomic analysis (AURA 2017). Though there have 
been some good beginnings, but very limited evidence based (Wozniak et al. 2017). The 
detailed tracking of the resistance gene and its flow in the overall environment is key to 
understand their pattern for effective measures to control such instances.  
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The majority of these isolates have been found extracted from urine samples (Azap et al. 2010). 
The whole genome sequencing of isolates will generate the complete genome nucleotide 
sequence (Lepuschitz et al. 2019) and compare SNPs (Single Nucleotide Polymorphism) 
between isolates, thus identifying the gene mutations. Sequence similarity with known 
genomes will be used to observe genotypic changes or possibly functional virulence factors 
associated with it (da Silva et al. 2012). The evolutionary relationship of the resistant strain 
with other collected or existing nucleotide or protein databases will be assessed by making 
phylogenetic trees (Mushtaq at al. 2011). The differences in the whole genome tree versus the 
resistance gene tree denotes the spread of resistance not by inheritance, and comparison of the 
whole genome phylogeny shows transmission between and through people, hospitals and the 
environment.  
Different online tools and software are available to generate the phylogram of the isolates and 
related sequenced genomes in the public domain. We used the Snippy tool for this. This tool 
help find variants between the reference genome and the sequence reads (Victorian 
Bioinformatics Consortium, 2014). 
 
 
1.3.3 Metagenomics in clinical diagnosis 
    The traditional method for pathogen detection for a disease relies on the identification of the 
causative agent that is already known based on the clinical symptoms. This is more focused on 
the routine tests and the repeated series of medication for all kind of patients which is imposing 
unprecedented challenges to tackle the emerging and novel pathogens.  Metagenomics has the 
potential to detect any status of pathogen, irrespective of the origin and novelty through the use 
of next generation sequencing (Miller at al. 2013). It is a very strong platform that uses 
bioinformatics tools to compare the pool of the biological databases which is helpful in species 
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and strain detection with accuracy. The genome sequence information is helpful in 
identification of virulence factors, any resistance genes associated with the disease (Robinson, 
Walker & Pallen 2013). Identification of novel pathogenic species is its other big scope 
(Greninger et al. 2010). There are several cases that have proved metagenomics as a useful tool 
in complex disease management. For instance, using shotgun sequencing, African swine fever 
virus-like sequence was detected as new member of Asfariviridae using metagenomics (Wan 
et al. 2013). Further there was the detection of unexpected isolates from stool samples whose 
prior information was not available (Loman et al. 2013). All of these are just a few examples. 
The pipeline for the laboratory and bioinformatics methods required for the metagenomic 
detection of pathogen is diverse. There are various choices of the computer software that are 
employed for this based on the type of isolates, required data sensitivity and bioinformatics 
pipeline to be followed. 
The laboratory pipeline includes the extraction and purification of the nucleic acid 
(DNA/RNA) from the environment source which can be from a patient, animals or 
environment. This is followed by Sequence library preparation. It is the process of ligating 
specific adaptor oligos to the fragments of nucleic acid to be sequenced.   Different commercial 
kits are available for both of these steps. The bioinformatic pipeline begins with sequencing 
generating raw reads of the DNA library. The quality of this data is then checked in FastQC 
software that provides Q score to define the quality of the read. Q score is the number that 
denotes the quality of the reads.  The good quality reads are then filtered and converted to fasta 
format by removing the read quality information. The reads are then mapped to all known 
peptides or nucleotides using a fast mapper such as Diamond Blast. The blast output can then 
be loaded into metagenomics software for analysis. Some metagenomics software has its own 
inbuilt mapping tools or custom read alignment algorithms. 
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1.4 Objectives 
This research is a part of bacterial genomics that involve the molecular extraction of bacterial 
DNA (Pseudomonas aeruginosa, Escherichia coli and species of Enterobacter) followed by 
qualitative and quantitative sequencing analysis with the aim to unravel the genetic determinant 
of outbreak and antibiotic resistance. Its objective is to explore the phylogeny of all group of 
these bacteria related to its virulence. Antibiotic resistance genes will be traced. The genotype 
of the clinical isolates will be identified using high throughput sequencing. Change in the 
genotype will be traced by comparing with the public database to observe any forms of 
mutation, the state of resistance genes, their size, positions and how that is related to current 
infection rate in the hospitals or ICUs.  The ancestral history of the identified strains will be 
used to counter their relatedness with other pathogens. This is being to prevent infection 
through reliable diagnosis in the healthcare setting. 
1.5 Aims 
1. Isolation and screening of ESBL bacteria through microbiological assays.  
2. DNA extraction and library preparation of the clinical isolates. 
3. Identify genotypes of clinical isolates through high throughput sequencing.  
4. Determine the relatedness of the identified strains through phylogenetic analysis.  
5. Correlative study of the resistance outbreak with environmental metagenomics data.  
 
 
 
 23 
 
CHAPTER II - MATERIALS AND METHODS 
2.3 Research Design  
This is comprehensive collaborative research and involves three main projects and two 
sub-projects under the first and the last main project. It is a joint effort of University Hospital 
Geelong; Australian Clinical Laboratory; Deakin Genome Centre, Deakin University, Waurn 
Ponds, Geelong, Australia and my post-graduate thesis.  The list of each of the projects are 
presented below.  The basic methodology for all of these projects is quite similar which begins 
with sample collection followed by microbiological analysis, DNA extraction and Library 
preparation and Sequencing. This section presents the common methodology for all of the 
different projects included in this thesis. 
 
Project I: Pseudomonas aeruginosa strain identification, antibiotic resistant genes in 
immunocompromised inpatients at University Hospital Geelong (n=30). 
This project begins back in 2019. At the time of onset of this thesis work, it was in genomic 
analysis stage. This step is after sequencing which is the analysis of the genomic statistics of 
individual Pseudomonas isolates, their ancestral history and observation of the potential 
antibiotic resistance. The details of all these analyses are presented in the result section. 
Sub-Project I.I Case study of a hematology patient died of Pseudomonas aeruginosa 
infection. 
This is a case study of a 52 years old male inpatient from the hematology units of the hospital 
who died because of Pseudomonas aeruginosa infection. Samples EA-86 and EA-87 derived 
from the patient were subjected to genome analysis for the investigation. 
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Project II: Study of Escherichia coli outbreak from health care facility in Barwon region 
(n=12). 
This was the project which I was involved completely from sample collection till the genomic 
analysis at the end.  Twelve samples from the health care setting was taken for this project. It 
includes samples both from the hospital and aged care home.   
Project III: Metagenomic profiling of unknown clinical isolates (n=57). 
This project also begins at the similar time as of Project- I. I got involved in it at the 
metagenomic part for its strain identification. All the fifty-seven samples were taken from 
inpatients at different units of hospital with a wide range of complications. 
 Sub-project III.I Discovery of the novel Enterobacter species. 
This involves genetic exploration of sample EA-30 as a potential pathogenic novel species of 
Enterobacter species. This sample was taken from a 74 years male patient’s urinary tract. 
Further investigations are presented in the section below. 
 
2.2 Methodology 
All of the above-mentioned projects have the common flowchart for the methodology which is 
described in the section below.  
2.2.1 Sample Collection  
For Project I, thirty samples of blood were taken from immunocompromised inpatients at 
University Hospital Geelong. They were labelled EA-001 to EA-30 and EA-086 and EA- 87. 
There were some missing genomes in between so in total there was thirty samples. All the 
samples were from haematology patients taken during the period of 2017-2019. For the case 
study, the last two samples, EA-086 and EA- 87, were taken into consideration. The samples 
were collected from the health professionals from University Hospital Geelong. 
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For project II, twelve samples of urine were collected from University Hospital Geelong and 
Aged care home, Geelong by professional health workers following safety procedures and 
ethical concerns from the patients. They are labelled R1-R6 for resistant (Extended Spectrum 
Betas Lactamase) ESBL isolates and S1-S6 for the sensitive one. 
They were transported safely to the laboratory and were cultured within two hours of collection.   
Urine culture was subjected to subculturing followed by identification with 2018 Bruker 
Daltonik GmbH, (Breame Germany biotyper database). Antimicrobial susceptibility testing 
was performed through Vitek II; bio- Mérieux, France.  
For project III, all fifty-seven blood samples were collected from patients at different units of 
the hospital. The similar procedure for blood sample collection as of Project I was followed for 
these (EA-29 to EA-85) unknown clinical isolates.  
  
 
2.2.2 Microbiological Screening 
Clinical isolates from Project I were cultured on blood agar plates and strain were confirmed 
by Matrix Assisted Laser Desorption /Ionization- Time of Flight (MALDI-TOF), which is a 
type of mass spectrometry prior to the beginning of my thesis.  Similar procedure for culture 
and strain identification was followed for Project III and its sub-project. 
For project II, routine urinalysis of all specimen was performed on the Sysmex UX 2000 
automated analyser followed by microscopic examination of cells. A phase contrast 
microscope was employed for this. Further, samples were enriched using broth in beads and 
subjected to growth in Blood agar at 37 °C for 24 hours at Clinical Laboratory, Geelong. Some 
colonies with less distinct growth were further cultured by radial streaking to obtain separate 
colonies for downstream process. 
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2.2.3 DNA extraction 
The isolated colonies of all the above clinical isolates were used for extraction of DNA at 
Australian Rickettsia Laboratory. It was performed using HiYieldTM Genomic DNA Mini Kit 
(Blood/Bacteria/Cultured Cells) protocol (Catalogue No. YGB100/YGB300) from Real 
Genomics with slight modifications. Four colonies of each cultured bacterial cells were 
transferred to a 1.5ml microcentrifuge tube containing 500µl of phosphate buffered saline. 
200µl of this sample was pipetted in a new microcentrifuge tube. To this sample, 200µl of GB 
Buffer was added and vortexed for 5 seconds. The sample was incubated at 70 °C water bath 
for 10 min until the sample lysate was clear. During incubation, the tube was inverted every 3 
minutes. The Elution Buffer (100 µl per sample) was preheated. 200 µl of 100% ethanol was 
added to the sample lysate and mixed immediately by vortexing for 10 seconds. Precipitate was 
broken by pipetting. A GB column was placed in a 2ml Collection Tube, All the mixtures from 
the previous step was applied to the GB column. The cap was closed and centrifuged at 20800 
rpm for 2 minutes. The 2ml Collection tube containing the flow-through was discarded and the 
GB column was placed in a new 2 ml Collection Tube. 400 µl of W1 Buffer was added in the 
GB column. The sample was centrifuged at 20800 rpm for 30-60 seconds. The flow-through 
was discarded and the Gb Column was placed back in the 2ml Collection Tube. 600 µl of Wash 
Buffer was added in the GB Colum and centrifuged at 20800 rpm for 30-60 seconds. The flow 
through was discarded and the GB column was placed back in the 2ml Collection Tube. The 
sample was centrifuged at 208000 rpm for 3 minutes to dry the column matrix. The dried GB 
Column was transferred back into a clean 1.5ml microcentrifuge tube. 100 µl of pre-heated 
Elution Buffer was added into the centre of the column matrix. The column and 
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microcentrifuge tube were allowed to stand at room temperature for at least 3 minutes and 
centrifuged at 15000 rpm for 3 minutes to elute purified DNA.  
 
   2.2.3.1 Qubit assay 
The extracted DNA concentration was measured using both Nanodrop and Qubit 2.0 
Fluorometer, Thermo Scientific to ensure the desired optimum concentration required for the 
library preparation. Working solution (WS) was prepared by mixing 1 µl of Qubit reagent with 
199 µl of Qubit buffer. The fluorometer was then standardised by using 10 µl of standard 
solution with 190 µl of WS. Once this was successful, 2 µl of each sample was mixed with 198 
µl of WS to determine its concentration.   
 
   2.2.3.2 Agarose Gel Electrophoresis 
The integrity of the DNA was further checked by performing Agarose Gel Electrophoresis. 
1.5% gel was prepared in 1X TAE and was cast in an electrophoresis tank with comb. 1 µl of 
the sample was mixed with 2 µl of loading dye and was loaded in each well connected with 
power supply. It was then allowed to run in the gel filled with 1xTAE for around 30 minutes. 
The DNA band then was observed on a UV Transilluminator. 
 
2.2.4 DNA Library Preparation 
The intact DNA was used as source for library preparation. It was performed in the PC2 
laboratory of School of Medicine, Deakin University. Illumina Nextera DNA Flex Library 
Prep kit (Catalogue Number 20018704) and guide was followed with slight modification in 
different steps.  
100 ng of each DNA sample was prepared by addition of calculated amount of a Nuclease Free 
Water (NFW) to make 30 µl in volume. 11 µl of resuspended BLT and same volume of TB1 
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mix was prepared, vortexed and 20 µl of this aliquoted mix was added to the sample.  It was 
slightly pipetted, sealed and set on a programmed thermocycler.  The conditions of the 
thermocycler were preheated lid at 1000 C, 550 C for 15 min and hold at 100 C to a reaction 
volume 50 µl.  
10 µl of the TSB was added to the above tagmentation reaction; it was slowly pipetted to 
resuspend the beads. This sealed tube was again run on the thermocycler with slight 
modification than in the above step. 370 C for 15 min for 60 µl of reaction volume. The tubes 
were kept in a magnetic stand; supernatant was discarded using a multichannel pipette followed 
by the washing step for two times. The tubes were removed from the stand and 100 µl of TWB 
was slowly added; pipetted to resuspend the beads. The tubes were placed back in the magnetic 
stand and waited for clear liquid; supernatant was discarded.  
Enhanced PCR mix was prepared for the amplification of tagmented DNA by the addition of 
22 µl of EPM and same volume of NFW; vortexed and centrifuged at 2000 rpm for 30 sec. It 
was transferred to the magnetic stand, waited for separation and the supernatant was discarded. 
After removing from the magnet, 40 µl of PCR mix was immediately added onto the beads; 
mixed until beads were fully resuspended and centrifuged as above. 10µl of the pre-paired i7 
and i5 index adapters was added to the sample; mixed well and centrifuged briefly as above. 
The thermal cycler condition was set and run for BLT- PCR program. This includes preheating 
the lid to 1000 C, 680 C for 3 min, 980 C for 3 min; 7 cycles of 980 C for 45 sec, 620 C for 30 sec 
and 680 C for 2 min; 680 C for 1 min and final hold to 100 C.  
Small PCR amplicon input procedure was practised for cleaning up the libraries. The amplified 
mix was centrifuged and placed on the magnetic stand for 5 min. 45 µl of supernatant was 
transferred to new tube onto which 81µl of SPB was added; was slowly pipetted and settled at 
room temperature for  5 min. It was placed on the magnetic stand, allowed to settle and 
supernatant was discarded. Washing was done by adding freshly prepared 80% ethanol, 
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incubated for 30 sec and removing the supernatant. The tube was air dried for 5 min, removed 
from the stand where 32 µl of RSB was added; was resuspended and allowed to sit at room 
temperature for 2 minutes. Finally, the tube was placed on the magnetic stand for 2 min. The 
supernatant obtained was transferred to a new tube which was our desired library. 
 
   2.2.4.1 Quality Control of the Prepared library 
The concentration of prepared library was measured by the Qubit method following the 
procedures from section 3.1.  while its size profile was analysed by Agilent Technology 4200 
TapeStation Software A (02).02. This was performed at Deakin Genome Centre.  D5000 
Screen Tape was used for this process. The protocols on Agilent D5000 ScreenTape System 
Quick Guide was optimised.  The ladder was prepared by adding 2 µl of HS buffer with the 
same volume of HS ladder. Similarly, the sample was prepared by adding 2 µl of HS buffer 
and 2 µl of the prepared DNA library.  They were spun and vortexed at 2000rpm for 1 min. 
The samples along with the ladder was loaded into a Tapestation instrument selecting the 
required samples on 2200 Tapestation Controller software. The result was presented in a 
filename we specified.   
 
2.2.5 Sequencing of the Prepared Libraries 
Eight successful libraries of Escherichia coli were submitted to Deakin Genome Centre, Waurn 
Ponds, Geelong for whole genome Sequencing. It was performed using Illumina NovaSeqTM 
6000 at the loading concentration of 450pM. S4 flow cell was used and the cycle for the 
sequencing reaction was 300. The protocol A of NovaSeq 6000 -Denature and Dilute 
Libraries Guide was referenced for the entire process. First of all, the DNA library was diluted 
to 0.2N for denaturation. It was then followed by the creation of the normalized library pool 
on S4 Flow Cell type which requires 16-20 Paired- end reads passing filter per flow cell and 
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approximately 250 libraries per lane. This was done using 10 mM Tris-HCL, pH8.5. The 
pooled library concentration was determined based on the desired final loading concentration 
which was about 2.25 nM. The normalized library was made a final volume of 310 µl, then 
centrifuged at 280x g for 1 minute. The full volume of the denatured library and PhiX was 
transferred to the library tube provided with NovaSeq 6000 Reagent Kit. It was then 
immediately loaded into the cluster cartridge to begin the process.  
 
2.2.5.1 Sequencing Clean-up  
The sequenced libraries generated the raw reads which were subjected to quality control by 
running fastp that estimates the amount of clean data, the adapters and the duplicate reads. fastp 
is an open source software that is helpful in quality profiling, adapter trimming, read filtering 
(Chen et al. 2018)! It accepts input file in fastq format and uses high level programming 
language like Python, Java to process the reads. The Q value determines the quality of the reads 
produced by sequencing. 
 
2.2.5.2 Genome Assembly  
This part of the research was done at AIMST University of Malaysia and the assembled 
sequence was provided for downstream analysis. Gene assembly is the process of aligning and 
merging of the sequences to reconstruct the original fragment. PATRIC 3.6.5 platform was 
used for genome assembly that provides the service via online site 
<https://patricbrc.org/app/Assembly2>. PATRIC, Patho-systems Resource Integration Center 
is an online site that allows the integrated biological data and access different analysis tools for 
the research of bacterial system.  The read files were uploaded, and the required parameters 
were set before starting the process. The read file is the fastq file containing the reads of 
sequence. It also allows comparison of the reads with multiple users of the existing PATRIC 
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database. Our reads were the illumina data, so the assembly strategy used was Unicycler which 
was selected during the run. Once assembled, the genomes were subsequently investigated at 
the genetic level for the characterisation. 
 
2.2.6 Genomic and phylogenetic analysis 
The Snippy tool v4.6.0 was used to prepare the phylogenetic tree. Five public genomes and 
NCBI reference genome was added from which all the SNPs were called. The tree was based 
on 175000SNPs. For the phylogenetic analysis, the very common SNPs were used. A 
phylogram for all of these species were based on 116,942 common SNPs. SNPs were computed 
from the PAO1 reference (GCF_000006765.1_ASM676v1) using Snippy software. Gubbins 
was used to remove SNPs found in potential horizontally transferred regions. The tree was 
calculated using FastTree with default parameters. 
 In all the projects, the PATRIC platform was used for genomic analysis of the clinical isolates 
for all the projects. <https://patricbrc.org/> The assembled genome of each isolate was added 
to this platform as a private addition.  The size, length, contigs, sequence, virulence and 
antibiotic resistance genes were then traced for each genome. The genome was then compared 
using BLAST platform to determine similarity and mismatch among public databases. This 
thus help trace the changes (indels), mutation and extent of modifications of genes among their 
closely related groups. The “Speciality genes” section in PATRIC was used to determine the 
number of antibiotic resistant gene and virulence factors for each isolate.  
 
2.2.7 Metagenomic analysis of the unknown clinical isolates 
It was performed by using bioinformatics tools and a pool of the existing biological database 
of the clinical isolates for project III. The quality assessed file of the sequenced genome (fastq) 
is firstly converted into fasta file, which is the readable file format for the BLAST (Basic Local 
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Alignment Sequence Tool) platform < https://blast.ncbi.nlm.nih.gov/Blast.cgi > This file was 
then blasted against NR peptides (2019) from GenBank. The output of the blast was loaded 
into Megan 6.14.2 downsampled to 1000 reads for each sample. The species of the isolate is 
then identified based on the matches with the respective genome read pool.  
 
 
CHAPTER III - RESULTS 
 
 3.1 Project I. Pseudomonas aeruginosa sequencing 
 
3.1.1 Genomic analysis of Pseudomonas aeruginosa 
Out of the thirty isolates, only Sample EA-1, from a patient at Urology department, was found 
to be multidrug resistant as determined by Antibiotic Susceptibility test (AST). The sequencing 
statistics of all these samples displayed a good correlation with the clinical metadata. All the 
statistical parameters; length, number of contigs, GC percentage and predicted genes for each 
individual isolate are within the typical ranges of P. aeruginosa sequenced by Illumina short 
reads (Table 1). This data also indicates the huge genomic diversity among the population of 
Pseudomonas species. In some cases, as in EA-21, the genome assembly statistics is 
abnormally high which is due to a mixture of the bacterial colony at the time of sample 
isolation. The genome size is less than usual in some sample like EA-20. This is due to huge 
portion of genome deletions in these isolates as a consequence of the rapidly changing genotype 
of the species. 
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Table 1: Genomic statistics of the sequenced genome of Pseudomonas sp. 
 
Genome ID Contigs Length (bp) GC Content (%) Predicted 
genes 
             EA-002 144               6373362            66.32 6001 
             EA-003 125               6546316             66.18 6249 
EA-004 108              6772685 66.10 6429 
EA-005 55 6568711 66.33 6193 
EA-007 82 6338104 66.47 5997 
EA-008 70 6310438 66.52 5916 
EA-009 123 6265511 66.47 5931 
EA-010 131 6688417 66.20 6356 
EA-011 149 6862427 66.10 6609 
EA-012 73 6348471 66.39 6007 
EA-013 99 6815305 66.23 6519 
EA-014 75 6440917 66.47 6090 
EA-015 55 6496553 66.41 6161 
EA-016 190 6094497 66.44 5862 
EA-017 89 6284750 66.55 5903 
             EA-019 231 7594049 65.19 7613 
EA-020 40 5041583 64.68 4734 
EA-021           7267 8560648 66.33             13484 
             EA-018 98 6342283 66.45               5990 
EA-022 92 6331540 66.43 5992 
EA-023 96 6494375 66.38 6094 
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EA-024 74 6245138 66.50 5895 
EA-025 106 6544832 66.30 6257 
EA-027 122 7059906 65.93 6873 
EA-028 71 6422275 66.45 6051 
EA-018 127 5066719 50.57 4981 
EA-006 56 4773870 55.56 4565 
              EA-001 86 6749476 66.19 6437 
               EA-86 90 6266206 66.30 5937 
               EA-87 91 6268050 66.30 5940 
 
 
 
3. 1.2 Phylogeny of the Pseudomonas isolates  
The closest public isolate (GCA) based on the number of Single Nucleotide Polymorphisms 
(SNP) was used to prepare the phylogenetic tree. (Figure 6) The red number on the branches 
gives the certainty of the branch topology and the length gives the genetic distance. It is quite 
interesting to note that most of the Pseudomonas aeruginosa isolates are more related to 
geographically dispersed isolates than to each other. None of the public isolates are related to 
the isolates in the Bellarine/Victorian region, except one from Melbourne. This is surprising. 
It's clear that Geelong/Barwon region isolates aren't derived from a common single source 
(except in a very few cases). The geographic information on the public isolates that are related 
to the Pseudomonas isolates are presented along with the tree (Figure 6). The location, source 
of extraction and year of detection, all are variably different for the closest match to these 
clinical isolates. This suggests that the infection of Pseudomonas species is from a very large 
pool of strains which are globally distributed. 
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Figure 6:  Phylogenetic tree of the Pseudomonas aeruginosa. 
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3.1.3 Antibiotic resistant genes of Pseudomonas aeruginosa genome: 
 
Almost all genomes of Pseudomonas have at least one hundred fifty  antibiotic resistance genes 
as determined by PATRIC. (Figure 7) Some have more than double the antibiotic genes and 
these genomes show the hallmark of sequenced mixed colonies. It happens in a few percent of 
colony picking events that mixtures of strains occur due to proximity of two colonies on a plate. 
Some isolates (EA- 3, 6, 22) have none of these gene as they are the missing genomes during 
sequence analysis, isolation or extraction. Isolate EA- 20 has significantly lower numbers of 
antibiotic resistant genes. This is likely due to large deletions in the genomes in this isolate. It 
is therefore elucidated that Pseudomonas species have developed frequent high levels of 
intrinsic mechanisms able to cope with antibiotic.  
 
 
Figure 7:  Bar chart representing the number of antibiotic resistant genes in Pseudomonas 
genome 
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3.2 Sub project I.I Case study of a Pseudomonas aeruginosa infection 
 
Isolates EA- 86 and EA-87 was isolated from the same patient. They exhibited different colony 
morphology in plated culture and antibiotic resistance pattern as determined through the 
available clinical metadata.  The genome size study shows that EA-87 possess an addition of 
around 2Kb of genome compared to EA-86 despite being isolated from same patients. There 
were three genes annotated in addition one extra contig generation in the EA-87 isolate. (Table 
2) Examination of annotation shows that the extra insert was unlikely to be a plasmid and is 
not protein coding.    
 
Table 2: Genomic parameters of the two isolates. 
 
 
SNP-wise analysis, using the PAO1 reference, the genomes of the two isolates are identical 
with none of hundred thousand of SNPs different. They are extremely closely related strains, 
with a few dozen private SNP mutations separating them. This is congruent with strain 
divergence within the host. The isolates are from the same strain which has mutated within the 
host. 
Further gene study reveals the gain of the three genes in EA87; is actually the result of the 
disruption of three Open Reading Frames (ORFs), splitting them into six smaller ORFs leading 
Sample 
ID 
Length 
(bp) 
GC% Contigs Predicted 
genes 
EA-86 6266206  66.30 90 5937 
EA-87  6268050  66.30 91 5940 
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to loss of function mutations in all three cases. In this kind of mutation, the ORF is broken 
down into smaller fragments thereby removing gene function. Three-point mutations were 
observed to be the cause of these mutations.  
 
 
 
 
 
 
 
 
 
 
The first mutation is the knockout of the drug efflux pump repressor (MexR) which controls 
expression of Mex multidrug efflux pump system. Knockout of this repressor is known to 
hyperactivate the efflux pump. This is a known antibiotic resistant mutation in Pseudomonas 
species (Figure 8) (Cabot et al. 2016). Such a mutation removes the antibiotics from the cell 
machinery making the strain more resistant to antibiotic therapy. This mutation is likely to have 
contributed to the death of the patient. The second mutation knocked out PA0041, an 
immunogenic large extracellular protein thereby rendering the strain less susceptible to attack 
by the hosts immune system. The third mutation knocked out oprB, a porin precursor, and there 
are a number of possible reasons this may have been advantageous to the bacterium such as 
decreasing the immunogenicity and other effects. This shows that the Pseudomonas genome 
has a significant tendency to mutation, and it is evolving rapidly, even while infecting a human 
host. 
Figure 8: Schematic representation of MexR efflux pump 
pump 
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3.3 Project 2. Escherichia coli from hospital and aged care home 
 
Urine sample were taken and was subjected to microbiological assay. Clinical metadata 
from Barwon Health was correlated and verified using the genomic tools from Deakin 
genomics. 
 
3.3.1 Culture of the isolate 
Round-shaped colonies were observed in the culture media.  The colony of isolates grown in 
Blood agar (Figure 1) is shown in the figure below. The morphology of the colony was entire, 
slightly bulged and separate colonies were observed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9: Escherichia coli colonies in 
Blood Agar 
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3.3.2 DNA extraction and Quantification 
A few colonies from the culture was used for DNA extraction. Concentration and purity were 
measured by Nanodrop and Broad Range (BR) Qubit are tabulated below. (Table 3) Among 
the twelve samples, R6 and S6 yields significantly less concentration of DNA and were not 
taken into consideration for further analysis. Measurement of low DNA concentration might 
be due to the presence of the impurities like phenolic components, EDTA salts or proteins.  The 
data from nanodrop differs from Qubit which may be basically due to differences in sensitivity 
of the instrument. We take into consideration the value of Qubit for further processing. 
A260/280 is the extent of purity of the DNA samples. Most of which are around 2 which 
demonstrate the considerable purity of the sample. 
Table 3: Quality Control readings of the extracted DNA 
Sample ID Nanodrop 
(ng/µL) 
A260/A280 Qubit (ng/µL) Remarks 
R1 19 1.87 12.6  
R2 53.3 1.90 33.7  
R3 83 1.89 53.9  
R4 74.1 1.94 48.6  
R5 74 1.88 53.6  
R6 3.1 1.9 1.04 Discarded 
S1 47.6 1.91 31.2  
S2 57.8 1.93 40.6  
S3 3.3 1.88 Not Detected Discarded 
S4 30.4 2.04 16.8  
S5 72.7 1.9 48.1  
S6 86 1.89 58  
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The intactness of the extracted DNA was examined on Agarose gel (Figure 10) which indicates 
Sample S3 and R6 to be faint and not essentially sound for library preparation. The Qubit 
concentration of the remaining ten samples were made to 100 ng/µL by addition of calculated 
amount of Nuclease free water for library preparation. The concentration of the prepared 
libraries as detected by Qubit and the Tapestation results are demonstrated in Table 4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TapeStation data represent the DNA fragment size range coverage of the prepared library and 
the concentration. Significant peaks were observed for most of the samples, except R3 and S2, 
with the desired size and concentration using the Tapestation software. 
Figure 10: DNA bands on Agarose Gel 
Electrophoresis. 
  S3.                                    R6 
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Table 4:  Quality assessment of the prepared library.  
 
Sample ID Qubit Reading 
(ng/µL) 
D500 Tapestation Result 
 
Remarks 
 Length (bp) Concentration 
(ng/µL) 
 
R1 17.5 910               28.7  
R2 6.48 772bp                 2.41  
R3 10.3 Flat Curve Discarded 
R4 6.94 816 3.09  
R5 12.5 582bp 26.5  
S1 14.7 922 11.3  
S2 6.15 Flat curve Discarded 
S4 5.98 904 2.11  
S5 17.7 811  15.8  
S6 1`4.2 870  20.8  
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3.3.3 Sequencing analysis of the isolates 
Eight prepared libraries were subjected to sequencing. The genome sequence analysis confirms 
all isolates (R1, R2, R4, R5 and S1, S5, S6) to be Escherichia coli except S4 which was found 
to be Kleibsiella oxytoca which contradicted with clinical metadata. 
The genomic statistics of the ESBLs isolates after whole genome sequencing and assembly in 
PATRIC is summarised in Table 5. The samples were similar in length, GC percentage and the 
coding regions, except for the K. oxytoca isolate.  Length represents the genome size of the 
isolates while GC percentage the percentage of the Guanine (G) and Cytosine (C) in the 
genome comprising Adenine, Cytosine, Guanine and Thymine. Contigs are the chunks of 
contiguous DNA generated after genome assembly. The number of predicted genes is also 
found to be significantly different between the resistant and sensitive isolates of E. coli.  Hence, 
they are unlikely to be related to each other genetically. 
            Table 5: Genomic attributes of E. coli derived from PATRIC. 
Sample ID Length (bp) GC (%) Contigs Predicted 
genes 
S1 4912684 50.536 81 4856 
S4 5965421 55.10 62 5795 
S5 4963073 50.55 67 4873 
S6 4709397 50.66 78 4592 
R1 5068677 
 
50.78 99 5062 
R4 5026741 
 
50.52 101 5035 
R5 5018795 50.75 99 4986 
R2     
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3.3.4 Analysis of antibiotic resistance among E. coli isolates: 
There are 42 known antibiotic resistance gene groups observed in these genomes. (Table 6) 
The majority of genes had complete Open Reading Frames (ORF) so there was complete gene 
coverage with about 100 intergenic gaps in each genome.  There was a fascinating 
observation with the presence of genes (BlaEC family, CTX-M family) in resistance strains 
which are completely absent in the sensitive strains and these gene families belongs to the Beta 
lactamase family. This indicate that R group has acquired variant of beta lactamase genes, 
while the S group has the more common beta lactamase genes. The difference in the sensitive 
and resistant strains was the variants of beta lactamase gene. 
Those strains with same gene group in both sensitive and resistant strains indicate the similarity 
in antibiotic response. Other groups with the partial presence or absence is not worth 
considering for antibiotic resistance analysis. To sum up, they all look like variants of the gene 
family conveying resistance. These are present in all the isolates but as a different variant. 
 
Table 6: Identification of Antibiotic resistance gene groups from PATRIC among the isolates. 
“1” in box indicate presence of one gene while blank box there are no genes from that group. 
Antibiotic resistant gene 
group 
R1 R2 R4 R5 S1 S5 S6 
AAC (3)-II, III, IV, VI, 
VIII, IX, X 
  
1 
    
APH (3'')-I 
 
1 1 1 
   
APH (6)-Ic /APH (6)-Id 
 
1 1 1 
   
AcrAB-TolC 1 1 1 1 1 1 1 
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AcrAD-TolC 1 1 1 1 1 1 1 
AcrEF-TolC 1 1 1 1 1 1 1 
AcrZ 1 1 1 1 1 1 1 
BcrC 1 1 1 1 1 1 1 
BlaEC 
    
1 1 1 
BlaEC family 1 1 1 1 
   
CTX-M family 1 1 1 1 
   
CatB family 1 
 
1 
    
EmrAB-TolC 1 1 1 1 1 1 1 
EmrD 1 1 1 1 1 1 1 
EmrE 1 1 1 1 
 
1 
 
EmrKY-TolC 1 1 1 1 1 1 1 
GadE 1 1 1 1 1 1 1 
GdpD 1 1 1 1 1 1 1 
H-NS 1 1 1 1 1 1 1 
KatG 1 1 1 1 1 1 1 
MacA 1 1 1 1 1 1 1 
MacB 1 1 1 1 1 1 1 
MarA 1 1 1 1 1 1 1 
MarB 1 1 1 1 1 1 1 
MarR 1 1 1 1 1 1 1 
MdfA/Cmr 1 1 1 1 1 1 1 
MdtABC-TolC 1 1 1 1 1 1 1 
MdtEF-TolC 1 1 1 1 1 1 1 
 46 
MdtL 1 1 1 1 1 1 1 
MdtM 1 1 
 
1 1 
 
1 
MexAB-OprM 
  
1 
    
Mph(A) family 
   
1 
   
OXA-1 family 1 
 
1 
    
OxyR 1 1 1 1 1 1 1 
PgsA 1 1 1 1 1 1 1 
QacE 
   
1 
   
SugE 1 1 1 1 1 1 1 
TEM family 
 
1 
     
Tet(A) 
   
1 
   
Tet(B) 1 
 
1 
    
TolC/OpmH 1 1 1 1 1 1 1 
gidB 1 1 1 1 1 1 1 
 
 
 
 
 
 
 
 
 
 
 
 47 
3.3.5 Phylogenetic Analysis of the E. coli samples: 
 
The phylogram of E. coli denotes their relatedness among each other (Figure 11) as 
represented by longer vertex distances using tree neighbouring. For each sequenced isolate the 
closest matching public genome was added to the phylogram based upon the number of 
common SNPs.  The isolates must be of different outbreak sources except for R2 and R5, which 
seems to be the same strain. Some of them are nearest to the public reference genomes GCA. 
Out of eight samples, the R1, R2 and R5 clade may have been from a common source. This 
has been verified by the high level of confidence 1 associated with this node of the phylogram. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.4  Project 3. Metagenomic profiling of Unknown Clinical samples 
Figure 11: Phylogenetic tree of the E. coli samples. 
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All the fifty-seven unknown clinical samples were subjected to bioinformatic analysis to 
determine the species. Almost all of these isolates belonged to Enterobacteriaceae family, the 
majority of which were Escherichia coli, Klebsiella sp. and Enterobacter sp. (Table 7). The 
identification of the isolates by metagenomic profiling had almost identical results as by mass 
spectrometry and culture-based methods in virtually all cases. Isolate EA- 30 was found to be 
a novel pathogenic species of the Enterobacter genus. 
 
         Table 7: List of identified species by metagenomic analysis. 
 
Sample Id Identified   Species 
EA-029 Escherichia coli 
EA-030 Enterobacter sp. (similar E. cloacae and 
E. hormaechei) 
EA-031 E. coli 
EA-032 E. coli 
EA-033 Staphylococcus epidermidis 
EA-034 Klebsiella sp. (similar K. pneumoniae and 
K. quasipneumoniae) 
 
EA-035 E. coli 
 
EA-036 Suspect new Enterobacter 
species. Enterobacter cloacae 2% of reads. 
EA-037 E. coli 
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EA-038 Klebsiella pneumoniae 
EA-039 Suspect new Enterobacter 
species. Enterobacter cloacae 4% of reads. 
EA-040 Klebsiella pneumoniae 
EA-041 Proteus mirabilis 
EA-042 Klebsiella pneumoniae 
EA-043 Klebsiella pneumoniae (maybe with 
large plasmid or new Klebsiella sp.) 
EA-044 E. coli 
EA-045 Klebsiella oxytoca 
EA-046 Klebsiella pneumoniae 
EA-047 Klebsiella pneumoniae 
EA-048 E. coli 
EA-049 Klebsiella sp. 
EA-050 E. coli 
EA-051 Klebsiella pneumoniae 
EA-052 E. coli 
EA-053 Klebsiella pneumoniae 
EA-053  
EA-054 Klebsiella oxytoca 
EA-055 E. coli 
EA-056 E. coli 
EA-057 Serratia marcescens 
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EA-058 E. coli 
EA-059 Enterobacter sp. (similar E. cloacae and 
E. hormaechei) 
EA-060 Klebsiella sp. (similar K. pneumoniae and K. 
variicola) 
EA-061 E. coli 
EA-062 E. coli 
EA-063 Klebsiella pneumoniae 
EA-064 E. coli 
EA-065 E. coli 
EA-066 E. coli 
EA-067 E. coli 
EA-068 Suspect new Enterobacter 
species. Enterobacter cloacae 3% of reads 
EA-069 E. coli 
EA-070 Suspect new Enterobacter 
species. Enterobacter cloacae 3% of reads 
EA-071 Klebsiella sp. (similar K. michiganensis) 
EA-072 E. coli 
EA-073 E. coli 
EA-074 Klebsiella pneumoniae 
EA-075 Enterobacter species. Enterobacter cloacae 
2% of reads. 
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EA-076 Klebsiella sp. (similar K. michiganensis) 
EA-077 E. coli 
EA-078 Klebsiella pneumoniae 
EA-079 E. coli 
EA-080 E. coli 
EA-081  Enterobacter 
species. Enterobacter asburiae 3% of reads 
EA-082 Klebsiella pneumoniae 
EA-083 Klebsiella pneumoniae 
EA-084 E. coli 
EA-085 Klebsiella pneumoniae 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.5  Sub- project 3.1 Novel Enterobacter species sequencing 
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The metagenomic analysis of all unknown clinical groups matched the supplied clinical data 
as verified by Whole genome sequencing (WGS). An interesting result is on Sample EA-30. 
This isolate was recovered from the blood of a patient at University Geelong Hospital, Victoria, 
Australia in 2017. This strain was Gram-stain-negative, facultatively anaerobic, motile and 
non-spore-forming. The sequencing of this isolate reveals the genetic content of the isolate to 
be different from the common Enterobacter group of bacteria. 
 
 
 
Table 8: Genetic features of the novel isolate 
 
 
 
 
 
The nearest match to this isolate is the Enterobacteriaceae bacterium 8376wB9 from bull faeces 
from Tanzania. About 1/12th of the genomes are 99% identical. Interestingly, the rest of the 
genomes are quite different. So, EA-030 is probably a new pathogenic species of Enterobacter. 
It represents the clinical isolate from an unknown clade of Enterobacter. There is a need to 
perform nanopore sequencing to make a contiguous genome suitable for publication in a quality 
journal. 
 
 
Sample 
ID 
  Length (bp)        GC%      Contigs  Number 
of genes 
EA-30      4773870        55.5 56       4565 
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CHAPTER IV - DISCUSSION AND CONCLUSION 
4.1 Discussion 
The upsurge in cases of hospital associated infections and the frequently changing landscape 
of the existing clinical isolates has posed a tremendous burden on the health sector. Different 
factors come into considerations in a way to address this situation. The antibiotic resistance 
profile, virulence factors and genome sequence analysis of the hospital bacteria need 
scrutinization to mitigate this issue (Mishra et al. 2020). Gram negative bacteria like 
Pseudomonas aeruginosa, Escherichia coli and species from Enterobacteriaceae are the major 
contributor of nosocomial infection. The rapid emergence of multidrug resistant and new 
clinical syndromes has been frequently documented in patients during treatment. As a result, a 
need for the robust clinical methodologies is deemed necessary. The use of next generation 
sequencing is emphasized to explore the horizon of knowledge of how the change in genotype 
within the bacterial strains affect the phenotypic expression of the disease. 
4.1.1 Pseudomonas aeruginosa from the Geelong region exhibit a great genetic diversity 
shown by wide geographic range of closest related genomes. 
Of all the isolates of Pseudomonas aeruginosa, most of them were closest related to 
geographically distant species as depicted by the phylogenetic tree. This demonstrates the 
incredible genetic diversity of Pseudomonas within a small region and the phenomenal global 
diversity of this species. There is high rate of their transmission among different age-group, 
gender and host environment and the ability to adapt in a novel and changing natural 
environment stably acts as reservoir causing human infections occasionally. 
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(Muthukumarasamy et al. 2020). Transmission is possible through a rapid movement of the 
people around the globe.  Ease of travelling has made this possible.   None of the single isolates 
is related to the one from Bellarine, and only one from the Victorian region. Either they are 
migrated through travellers or there can be the chance of a huge pool of diverse Pseudomonas 
genome inhabitants in the of Bellarine region.  These attributes cause opportunistic infections 
from hospital associated Pneumonia (HAP), urinary tract infection, to wound infection and 
septicaemia (Gomila et al. 2018).  SNP wise analysis of Pseudomonas aeruginosa reveals that 
they possess a huge genotypic pool which is attributed by the finding of this project.  
This is the vivid evidence that these isolates aren’t derived from a single common source. This 
suggests a high cross genetic variation among Pseudomonas and among the public isolates. 
According to Boles (2004) Pseudomonas aeruginosa undergo self-generated diversity in 
biofilms as a means to safeguard their community from adverse host or therapeutic 
environment and this pool of genetic diversity guarantees species survival to all but the most 
calamitous of global events! 
Similarly, the development of ancient antibiotic resistance in these isolates is evident by the 
presence of a wide family of antibiotic resistance genes in almost all the genomes. ESBL 
resistance has been found to transfer laterally among a generation while the family of 
carbapenems resistant variants are heterogeneously reported worldwide (Bonnin et al. 2018). 
Mutation of resistance genes in P. aeruginosa include overexpression of ß- lactamase AmpC 
or efflux pump, OprD inactivation and Quinolone Resistance determining region (QRDR) (del 
Barrio-Tofiño et al. 2017). Some genomes have evidence of double the number of Ab 
resistance genes, which is due to the mixture of the colonies at the time of sample extraction 
or be it at the time of isolate colony picking. The number of antibiotic resistance genes reflects 
they have developed sophisticated antibiotic resistant mechanisms to cope with exposure to a 
wide range of antibiotics used in in the hospitals and nursing homes. 
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Mutation is prominently observed among two isolates from the same source. This makes the 
routine diagnosis more challenging which can be life threatening to immunocompromised 
patients. The death of the patient in the case study project I.I shows that there remains the 
chance of multiple mutations even in a single ORF decreasing the immunogenicity and hence 
repressing the immune defence mechanism or by overexpressing MexAB-OprM operon (Pan 
et al. 2016) leading to antibiotic resistance. 
4.1.2 Escherichia coli infection are genetically diverse irrespective of their antibiotic 
sensitivity 
Escherichia coli are the common microbiota in the gut of human. Extensive study of this isolate 
is underway to uncover the ever-changing diversity of its genome. In this research, most of E. 
coli isolates were found unrelated to each other as confirmed by the genome assembly statistics. 
The difference in the host environment and the antibiotic susceptibility pattern validate this 
finding. The inherent potential of genomic plasticity and evolution through horizontal gene 
transfer is observed in E. coli. This gives rise to diverse virulence and antibiotic resistant 
mechanism that alter their genetic adaptability (Moriel et al. 2011). The presence of several 
mobile genetic elements like transposons, plasmids, and bacteriophages are responsible for 
acquiring the new attributes like ESBLs, high frequency of recombination, antibiotic resistance 
gene transfer, recombination and many other emerging features among this group.   
(Brzuszkiewicz et al. 2011; Scheutz et al. 2011). This can lead to a diverse range of infections 
like urinary tract infections and gastrointestinal illness. Their genome contains a conserved 
framework of genes which is capable of incorporating relatively different clusters of genes that 
may be tailored in future for the design of the genetic diagnostics that could determine 
pathogenicity and other characteristics of E. coli strains (Ellison 2002). 
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Two of the resistant strains were found to be same based on the genetic constituents.  There 
can be the chance of cross contamination among the isolates or they can be from the same 
infection source. Insufficient information was supplied in the clinical metadata to confirm they 
may be from a common source. One of the samples, S4, was found to be the member of 
Enterobacteriaceae in the group which can be due to opportunistic or secondary infections 
among immunocompromised old age people. One report presents a fact that around 20 percent 
of E. coli O157 outbreak cases are due to secondary spread which is influenced by the age and 
mode of primary transmissions (Snedeker et al. 2009). There is a high chance of secondary 
spread in old age homes and in hospitals given the age factor and weakened immune system.  
Antibiotic resistance in these isolates is evolving which is a parlous observation denoting a dire 
need to combat it in time. The emergence of multidrug resistant species is life threatening. 
Around 11% of the ESBL E. coli urinary tract infection around the globe are antibiotic resistant 
(Mazzariol, Bazaj & Cornaglia 2017). Beta lactamase resistance is variable among both the 
sensitive and resistant strains. This has narrowed the efficacy of the most frequently used 
antibiotics in health care settings such as Penicillins, monobactams and cephalosporin. 
Extended spectrum Beta Lactamases arise by the mutation of the beta lactam genes (bla family- 
blaTEM, blaSHV, blaCTX-M) (Bajpai et al. 2017). The presence of the bla gene and its variants in 
the resistant isolates presents a therapeutic challenge in infection control. They have acquired 
these gene over time through mutations or lateral gene transfer. Similarly, the presence of beta 
lactamase genes in both resistant and sensitive strains demonstrates a high rate of resistance 
development in this group of bacteria. Integrated health measures based on genotypic studies 
should be formulated to prevent the transmission of this bacteria in the community. This should 
be commensurate with   the needs of each community.  
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4.1.3 Metagenomics is crucial in disease diagnosis and determination of variant and 
novel species. 
Humans are susceptible to a wide range of infections. An accurate diagnosis of the causal agent 
is an important procedure in disease management. The use of bioinformatic tools has become 
crucial in understanding the variability among bacterial genomes. The availability of a huge 
pool of public biological databases has made it feasible to detect changes at the SNP level in 
different lineages. The origin, source of outbreak and its timing are clinically helpful 
parameters which can also trace the ancestral history to determine the relatedness of the 
isolates. This is helpful to decipher the relationship among the normal microbiota with the 
pathogens. The evolution of the modern sequencing tools has drastically changed the landscape 
of fundamental biology and is improving the diagnosis through efficient detection of virulence 
genes and antibiotic resistance (Padmanabhan et al. 2013).  
Metagenomics is one of most spectacular application of high throughput sequencing, often 
termed as Next Generation Sequencing (NGS), to identify all the DNA populations in 
polymicrobial specimen (Qin et al. 2010; Armougom et al. 2009). It deals with the diversity of 
microbial population with potential interactions and nature of relationship within the 
community (Sharon et al. 2013). In this research, we use metagenomic analysis to determine 
the taxonomy of the unknown clinical isolates from hospital samples based on the sequence 
similarity approach. This is basically the comparison of the Illumina sequence of the isolates 
to the public database, here GenBank’s, based on the NR peptides. The BLAST output 
represents the extent of similarity of the genome which is then compared in Meagan to 
determine the species at genus level.  In most of the isolates, the samples were subjected to 
verification by other methods (selective culture and mass spectroscopy) which was congruous 
to the genetic data with a few exceptions. Even phylogenetically related species can be 
accurately identified using matrix-assisted laser desorption/ionization time-of-flight mass 
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spectrometry (Nagy 2014). But for the population diversity study and significantly for the novel 
strains and pathogenic variant identification, an integrated metagenomics pipeline has no 
alternative.  
  
 
 
4.2 Conclusion  
There are a several promising hallmarks of this research which gives hope to an expansion of 
the horizon of the diagnostic world, especially hospital acquired infections. In the current 
exacerbating situation of nosocomial infection, research work like this could be helpful in 
tracking existing or probable pools of the bacteria that could be pathogenic to the humans.  
The multiple infections of Pseudomonas aeruginosa in Geelong are closest related 
geographically dispersed isolates. They are spread from different sources rather than a common 
one. Most of these isolates has a high level of intrinsic and acquired resistance mechanisms to 
counter most classes of antibiotics. The genetic variation due to mutation among the isolates 
thus challenge the traditional and routine infection control strategies. Thus, pseudomonas is a 
burning therapeutic challenge.  
Similarly, the Escherichia coli samples, both resistant and sensitive, have been found to spread 
from different source of outbreak. Resistant isolates (R) are not related to the Sensitive (S) 
ones. Despite being a common microbiota in the gut, high levels of genetic variation are 
observed in these isolates.  Beta lactamase resistance in these species is evolving, denoting the 
pressing need to explore their genetics to minimize hospital or aged care outbreaks. 
Further, metagenomic study is crucial in clinical outbreak management and reforming policies 
are necessary. The use of bioinformatic tools in analyzing the pathogenic isolates could be 
helpful in understanding their origin and dispersion in the nature. This provide insights to health 
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professionals to practice the stringent measures for their management to safeguard the public 
health.  In addition, mass spectroscopy and culture methods of species identification are 
predominantly congruent with whole genome sequencing. 
To sum up, antibiotic resistance, novel species and strain tracking can be all done 
simultaneously at the genomic level to elucidate the pathophysiology of hospital acquired or 
any other infections.  
 
 
 
4.3 Recommendation 
The use of genetic technology and bioinformatic tools in disease diagnosis should be a 
Hobson’s choice. This should be prioritized by every nation to fight any unprecedented 
outbreaks in the hospital or in the general public. There is no single alternative to genomic 
characterization of the clinical isolates in mitigating HAIs or any other infections. Genome 
sequencing is the vital tool for this. The antibiotic resistance and mutations have to be 
monitored using metagenomic analysis to create a strong database for infection control. All the 
concerned health authorities, researchers and government should work in coordination to 
unveil the standard procedures and preparedness for imminent disease outbreak and infection 
control. 
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